37
Table B1.
Share of treated and controls who had received Sassam and AM at different
occasions
Sassam
AM
S-treated S-control Diff. %
points
A-treated A-control
Diff. %
points
Dec -07
0.26
0.04
0.219***
(0.007)
0.06
0.04
0.016**
(0.006)
Jan -08
0.37
0.16
0.211***
(0.009)
0.11
0.08
0.026***
(0.009)
Feb -08
0.39
0.22
0.176***
(0.009)
0.14
0.10
0.037***
(0.010)
Mar -08
0.40
0.24
0.165***
(0.010)
0.16
0.12
0.039***
(0.010)
Apr -08
0.41
0.26
0.155***
(0.010)
0.17
0.14
0.037***
(0.011)
May -08
0.42
0.27
0.150***
(0.010)
0.19
0.15
0.042***
(0.011)
Jun -08
0.42
0.27
0.149***
(0.010)
0.20
0.16
0.041***
(0.012)
Jul -08
0.42
0.28
0.147***
(0.010)
0.20
0.16
0.043***
(0.012)
Aug -08
0.43
0.27
0.146***
(0.010)
0.21
0.17
0.042***
(0.012)
Sep -08
0.43
0.29
0.144***
(0.010)
0.23
0.18
0.043***
(0.012)
Oct -08
0.44
0.29
0.142***
(0.010)
0.24
0.19
0.045***
(0.012)
Nov -08
0.44
0.30
0.142***
(0.010)
0.25
0.21
0.043***
(0.013)
Dec -08
0.44
0.30
0.143***
(0.010)
0.26
0.23
0.033***
(0.13)
Jan -09
0.45
0.31
0.141***
(0.010)
0.28
0.24
0.037***
(0.013)
Feb -09
0.45
0.31
0.141***
(0.010)
0.30
0.26
0.036***
(0.013)
Notes: Standard errors are given within parentheses. T-tests have been performed to test
mean differences between the two groups. Number of observations, S-treated:
4,467, S-controls: 4,791, A-treated: 2,208, A-controls: 2,259. Data lack
information from Skåne and Västra Götaland. */**/*** indicates significance at
the 10/5/1 percent level.
